Off-label thrombolysis versus full adherence to the current European Alteplase license: impact on early clinical outcomes after acute ischemic stroke.
about
Reasons for exclusion from intravenous thrombolysis in stroke patients admitted to the Stroke Unit.Predictors of symptomatic intracranial haemorrhage in off-label thrombolysis: an analysis of the safe implementation of treatments in stroke registry.Clinical recovery and health-related quality of life in ischaemic stroke survivors receiving thrombolytic treatment: a 1-year follow-up study.Why not Intravenous Thrombolysis in Patients with Recurrent Stroke within 3 Months?
P2860
Off-label thrombolysis versus full adherence to the current European Alteplase license: impact on early clinical outcomes after acute ischemic stroke.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
2014年學術文章
@zh-hant
name
Off-label thrombolysis versus ...... s after acute ischemic stroke.
@en
Off-label thrombolysis versus ...... s after acute ischemic stroke.
@nl
type
label
Off-label thrombolysis versus ...... s after acute ischemic stroke.
@en
Off-label thrombolysis versus ...... s after acute ischemic stroke.
@nl
prefLabel
Off-label thrombolysis versus ...... s after acute ischemic stroke.
@en
Off-label thrombolysis versus ...... s after acute ischemic stroke.
@nl
P2093
P2860
P1476
Off-label thrombolysis versus ...... s after acute ischemic stroke.
@en
P2093
Anna Maria Musso
Domenico Sergio Zimatore
Francesco Donato
Giampaolo Tomelleri
Giorgio Tommasi
Giosuè Gulli
Giovanna Maddalena Squintani
Giuseppe Gambina
Giuseppe Moretto
Luciano Deotto
P2860
P2888
P304
P356
10.1007/S11239-013-0980-2
P577
2014-05-01T00:00:00Z